NexImmune | DEFA14A: Others
NexImmune | 8-K: Current report
NexImmune | 424B5: Prospectus
NexImmune | 8-K: Current report
NexImmune | 8-K: Current report
NexImmune | 8-K: Current report
NexImmune | DEFA14A: Others
NexImmune | 8-K: Current report
NexImmune | 8-K: Current report
NexImmune | 144/A: Others
NexImmune | 144/A: Others
NexImmune | 4: Statement of changes in beneficial ownership of securities-Director Roemer Alan S.
NexImmune | 144: Notice of proposed sale of securities pursuant to Rule 144
NexImmune | DEF 14A: Definitive information statements
NexImmune | 8-K/A: Current report (Amendment)
NexImmune: Q3 2023 Earnings Report
NexImmune | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
NexImmune | PRE 14A: Preliminary proxy statements relating to merger or acquisition
NexImmune | 8-K: Current report
NexImmune | 8-K: Current report
No Data